Navigation Links
Misonix Appoints Stavros Vizirgianakis to Board of Directors
Date:5/10/2013

FARMINGDALE, N.Y., May 10, 2013 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced today that Mr. Stavros Vizirgianakis has been appointed to the Misonix Board of Directors. The addition of Mr. Vizirgianakis expands the Misonix Board to seven members, with five members considered to be independent directors. Mr. Vizirgianakis is a Misonix shareholder, having acquired 5.3 percent of the Company's outstanding common stock in the open market in recent years.

Stavros Vizirgianakis has extensive medical device sales and marketing experience as a principal in Applied BioSurgical, a large medical device distributor in South Africa, and as a partner in MD Solutions Australasia PTY LTD, an Australian-based distributor of medical device products. Both companies are major distributors for a large number of medical device companies throughout the world.

Applied BioSurgical and MD Solutions have been exclusive distributors of Misonix products in their respective territories for many years. 

Mr. Michael A. McManus, Jr. , president and chief executive officer of Misonix, said, "We are very pleased to welcome Stavros Vizirgianakis to our Board of Directors. Stavros has a documented track record of success in marketing medical devices throughout the world.  I have gotten to know Stavros over the years as he has successfully sold our products internationally.  His industry knowledge, marketing experi
'/>"/>

SOURCE Misonix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Misonix Reports Nine Months Fiscal 2013 Financial Results
2. Misonix Announces New Distribution Agreement For Denmark
3. Misonix Reports Financial Results for First Half of Fiscal 2013
4. Misonix Presents at MicroCapClub Invitational
5. Misonix Terminates Distribution Agreement With Aesculap
6. Misonix Reports Strong Revenue Increases for the First Quarter of Fiscal 2013
7. Misonix Reports Strong Revenue Increases for the Three Months and Full-Year Ended June 30, 2012
8. Misonix Product Featured At Neurosurgery Congress
9. Misonix Adds 6 Spine Sales Agencies In The U.S.
10. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
11. Misonix Inks New Distribution Agreement For Croatia And Slovenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 20, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... for the Phase 1 study of MM-302, a ... cancer.  The results were presented today by Patricia ... session at the 2015 American Association for Cancer ... PA. Data described the safety and ...
(Date:4/20/2015)... April 20, 2015  Sigma-Aldrich Corporation (Nasdaq: ... (CR) Magazine,s list of the 100 Best Corporate ... corporate responsibility performance.  Sigma-Aldrich ranked fifth, its highest ... the list. "We are honored to ... efforts and we are extremely pleased with our ...
(Date:4/20/2015)... April 20, 2015 The preclinical contract research organization ... of drugs and safety testing of medical devices, announces that ... this week,s workshop " Drug Transporters in ADME: From the ... . The title of Dr. Hidalgo,s talk is "Modern ... session entitled "Transporter Tools of the Future." The ...
Breaking Medicine Technology:Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 2Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 3Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 4Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 5Sigma-Aldrich Named to CR Magazine's 100 Best Corporate Citizens List 2Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters 2
... YORK, Oct. 7, 2011 Intellect Neurosciences, Inc. (OTCBB: ... clinical-stage pipeline, and multiple licenses with major pharmaceutical companies ... interview with Dr. Daniel Chain, Ph.D., Chairman and CEO ... Dr. Chain will be discussing the state ...
... Health Solutions, Inc. (NYSE: MHS ) today ... the Silver Award for Best Practices in Health Care ... healthcare accreditation organization, during the URAC 12th Annual Quality ... ) Medco,s program was selected as one ...
Cached Medicine Technology:Intellect Neurosciences CEO to be Featured on Wall Street Reporter 2Medco Wins 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection 2Medco Wins 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection 3
(Date:4/21/2015)... 2015 CALNOC, the nation’s first nursing ... RN, FAAN, will keynote their upcoming conference – Navigating ... CA on October 26, 2015. , Dr. Burnes ... of Nurse Executives (AONE) and the first African American ... American Academy of Nursing and the National Black Nurses ...
(Date:4/21/2015)... VA (PRWEB) April 21, 2015 The Science ... as a special addition to its Lunch Break Science program. ... World of Quarks! – taking guests from the subatomic world ... form. , The Museum invites members of the community to ... the Jefferson Lab physicist. Guests will delve into the nucleus ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Renewable energy, ... a few of the Earth Day topics USM ... and national leaders debate the affect of climate change ... variety of subject matter touching on the environmental concerns ... segments will delve into sustainable lifestyles, clean air options, ...
(Date:4/21/2015)... April 21, 2015 On Saturday, May ... the rest of his team from Georgia Eye ... to End Lupus Now, being held in Piedmont Park ... Walk proved to be the largest LFA-sponsored walk in ... effort to raise funds and awareness for lupus, an ...
(Date:4/21/2015)... 21, 2015 Invictus Medical has ... Illinois university for a second innovative technology aimed ... conducive to newborn infants’ cognitive development. , “This ... problems we have identified through extensive interviews and ... George Hutchinson, Invictus Medical’s Chief Technology Officer. “We ...
Breaking Medicine News(10 mins):Health News:Nationally Recognized Nurse Leader Linda Burnes Bolton to Present Keynote Address at CALNOC Conference 2Health News:Quarks and Forks at the Science Museum of Virginia 2Health News:USM Studios’ Programming Focuses on the Environment 2Health News:9th Annual Walk to End Lupus Now 2Health News:9th Annual Walk to End Lupus Now 3Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2
... Drug Administration is scrutinizing the claims made by a ... to the claims made by the businessman Allan Lord, he ... The Bio-Germ Protection kits contain skin lotion, a nasal spray, ... online. ,According to the company, the lotion, which is ...
... 'Transcranial Magnetic Stimulation' (TMS) maybe the way forward ... aggressive electro-shock therapy., ,Electro-Shock Therapy or ECT is ... treat severe depression for many decades. However, it can ... and requires general anesthesia. In ECT the doctors pass ...
... can prevent the spread of melanoma// and other forms of ... a chemical found in turmeric, can block a biological pathway ... The chemical in the spices inhibits a protein called nuclear ... abnormal inflammations that can lead to a number of disorders ...
... revealed that consumption of fruits, vegetables and foods high in ... risk of heart disease. ,Western cuisines are not so ... plant foods in the diet. ,10 healthy individuals were ... to each of them. The diets were a vegetarian diet ...
... be responsible for various immune deficiency syndromes, and researchers// ... two different form of immune deficiency conditions called immunoglobulin ... ,Immune deficiency syndrome may be hereditary or acquired. Hereditary ... defects in the cells and tissues that are responsible ...
... help in the brain development of foetus and infants for ... administered to pregnant women. A new study conducted by scientists ... slow down the cognitive decline in middle-aged subjects. , ... and women) with increased levels of homocysteine. This amino acid ...
Cached Medicine News:Health News:A New Product Offering protection against anthrax 2Health News:Strong Magnetic Stimulation Can Help Treating Severe Depression 2Health News:Fibre Rich Food A Boon For Lowering Cholesterol 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: